CARDIOVASCULAR JOURNAL OF AFRICA • Volume 27, No 3, May/June 2016
AFRICA
183
Human Retroviruses
2013;
29
(3): 557–563.
25. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentra-
tion of low-density lipoprotein cholesterol in plasma, without use of the
preparative ultracentrifuge.
Clin Chem
1972;
18
(6): 499–502.
26. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF,
Turner RC. Homeostasis model assessment: insulin resistance and beta-
cell function from fasting plasma glucose and insulin concentrations in
man.
Diabetologia
1985;
28
(7): 412–419.
27. Haffner SM, D’Agostino R, Saad MF, Rewers M, Mykkänen L, Selby
J,
et al
. Increased insulin resistance and insulin secretion in nondiabetic
African-Americans and Hispanics compared with non-Hispanic whites.
The Insulin Resistance Atherosclerosis Study.
Diabetes
1996;
45
(6):
742–748.
28. Evans J, Goedecke JH, Söderström I, Burén J, Alvehus M, Blomquist C,
et al
. Depot- and ethnic-specific differences in the relationship between
adipose tissue inflammation and insulin sensitivity.
Clin Endocrinol
(Oxf) 2010;
74
(1): 51–59.
29. Emanuela F, Grazia M, Marco DR, Maria Paola L, Giorgio F, Marco
B. Inflammation as a link between obesity and metabolic syndrome.
J
Nutr Metab
2012;
2012
(12): 1–7.
30. Hotamisligil GS. Molecular mechanisms of insulin resistance and the
role of the adipocyte.
Int J Obes Relat Metab Disord
2000;
24
(
Suppl
4): S23–27.
31. Manolopoulos KN, Karpe F, Frayn KN. Gluteofemoral body fat as a
determinant of metabolic health.
Int J Obes Relat Metab Disord
2010;
34
(6): 949–959.
32. Frayn K. Adipose tissue as a buffer for daily lipid flux.
Diabetologia
2002;
45
(9): 1201–1220.
33. Jensen MD, Haymond MW, Rizza RA, Cryer PE, Miles JM. Influence
of body fat distribution on free fatty acid metabolism in obesity.
J Clin
Invest
1989;
83
(4): 1168–1173.
34. Lemieux I. Energy partitioning in gluteal-femoral fat: does the meta-
bolic fate of triglycerides affect coronary heart disease risk?
Arterioscler
Thromb Vasc Biol
2004;
24
(5): 795–797.
35. Chantler S, Dickie K, Micklesfield LK, Goedecke JH. Longitudinal
changes in body fat and its distribution in relation to cardiometabolic
risk in black South African women.
Metab Syndr Relat Disord
2015;
13
(9): 381–388.
36. Berenson AB, van den Berg P, Williams KJ, Rahman M. Effect of
injectable and oral contraceptives on glucose and insulin levels.
Obstet
Gynecol
2011;
117
(1): 41–47.
37. Dickie K, Micklesfield LK, Chantler S, Lambert EV, Goedecke JH.
Meeting physical activity guidelines is associated with reduced risk for
cardiovascular disease in black South African women; a 5.5-year follow-
up study.
BMC Public Health
2014; 14(1): 1–11.
38. Marotta T, Russo BF, Ferrara LA. Triglyceride-to-HDL-cholesterol
ratio and metabolic syndrome as contributors to cardiovascular risk
in overweight patients.
Obesity
(Silver Spring) 2010;
18
(8): 1608–1613.
39. McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G. Use
of metabolic markers to identify overweight individuals who are insulin
resistant.
Ann Intern Med
2003;
139
(10): 802–809.
40. Hu G, Bouchard C, Bray GA, Greenway FL, Johnson WD, Newton
RL,
et al.
Trunk versus extremity adiposity and cardiometabolic risk
factors in white and African American adults.
Diabetes Care
2011;
34
(6):
1415–1418.
41. Vega GL, Adams-Huet B, Peshock R, Willett D, Shah B, Grundy SM.
Influence of body fat content and distribution on variation in metabolic
risk.
J Clin Endocrinol Metab
2006;
91
(11): 4459–4466.
42. De Oliveira E Silva ER, Foster D, McGee Harper M, Seidman CE,
Smith JD, Breslow JL,
et al
. Alcohol consumption raises HDL choles-
terol levels by increasing the transport rate of apolipoproteins A-I and
A-II.
Circulation
2000;
102
(19): 2347–2352.
43. Punyadeera C, van der Merwe MT, Crowther NJ, Toman M, Schlaphoff
GP, Gray IP. Ethnic differences in lipid metabolism in two groups of
obese South African women.
J Lipid Res
2001;
42
(5): 760–767.
44. Sliwa K, Lyons JG, Carrington MJ, Lecour S, Marais AD, Raal FJ,
et
al
. Different lipid profiles according to ethnicity in the Heart of Soweto
study cohort of de novo presentations of heart disease : cardiovascular
topics.
Cardiovasc J Afr
2012;
23
(7): 389–395.
45. Hosain GMM, Rahman M, Williams KJ, Berenson AB. Racial differ-
ences in the association between body fat distribution and lipid profiles
among reproductive-age women.
Diabetes Metab
2010;
36
(4): 278–285.
46. Porter SA, Massaro JM, Hoffmann U, Vasan RS, O’Donnel CJ, Fox
CS. Abdominal subcutaneous adipose tissue: a protective fat depot?
Diabetes Care
2009;
32
(6): 1068–1075.
47. Garg A. Acquired and inherited lipodystrophies.
N Engl J Med
2004;
350
(12): 1220–1234.
48. Klein S, Fontana L, Young V, Coggan A, Kilo C, Patterson B,
et al.
Absence of an effect of liposuction on insulin action and risk factors for
coronary heart disease.
N Engl J Med
2004;
350
(25): 2549–2557.
49. Heilbronn L, Smith SR, Ravussin E. Failure of fat cell proliferation,
mitochondrial function and fat oxidation results in ectopic fat storage,
insulin resistance and type II diabetes mellitus.
Int J Obes
2004;
28
:
S12–S21.
50. Sánchez-López M, Ortega FB, Moya-Martínez P, López-Martínez S,
Ortiz-Galeano I, Gómez-Marcos MA,
et al.
Leg fat might be more
protective than arm fat in relation to lipid profile.
Eur J Nutr
2012;
52
(2): 489–495.